Patents by Inventor Dwight B. DuBois

Dwight B. DuBois has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7341153
    Abstract: A specimen package includes a top, a first side, connected to the top, a bottom, connected to the first side, and a second side, connected to the bottom. The package also includes therein an internal separator. The internal separator forms a first compartment and a second compartment within the package. The top includes a window for viewing the first compartment. The bottom includes a second window for viewing the second compartment. The top, the first side, the bottom, the second side, and the internal separator can all be formed by folding a shaped planar sheet. The first compartment can contain a specimen, placeable within the first compartment. The second compartment can contain a label, placeable within the second compartment. The specimen is viewable through the first window, and the label is viewable through the second window.
    Type: Grant
    Filed: July 3, 2003
    Date of Patent: March 11, 2008
    Inventors: Dwight B. DuBois, Timothy W. Murray
  • Patent number: 7033749
    Abstract: The present invention relates to nuclease resistant nucleic acids in general and ribonuclease resistant RNAs in particular. Methods of making and using such nucleic acids are disclosed.
    Type: Grant
    Filed: April 10, 2002
    Date of Patent: April 25, 2006
    Assignees: Ambion, Inc., Cenetron Diagnostics LLC
    Inventors: Brittan L. Pasloske, Dwight B. DuBois, David M. Brown, Matthew M. Winkler
  • Publication number: 20030077622
    Abstract: The present invention relates to methods and compositions that provide a positive control to identify inhibition during a signal amplification reaction. The methods and compositions of the present invention are designed to run in the same tube or assay environment as the experimental or target sample and contain a copy of the target sequence in an inverted form.
    Type: Application
    Filed: May 24, 2002
    Publication date: April 24, 2003
    Inventors: Cindy R. WalkerPeach, Dwight B. DuBois
  • Publication number: 20020192689
    Abstract: The present invention relates to nuclease resistant nucleic acids in general and ribonuclease resistant RNAs in particular. Methods of making and using such nucleic acids are disclosed.
    Type: Application
    Filed: April 10, 2002
    Publication date: December 19, 2002
    Inventors: Brittan L. Pasloske, Dwight B. DuBois, David M. Brown, Matthew M. Winkler
  • Patent number: 6399307
    Abstract: The present invention relates to nuclease resistant nucleic acids in general and ribonuclease resistant RNAs in particular. Methods of making and using such nucleic acids are disclosed.
    Type: Grant
    Filed: September 19, 2000
    Date of Patent: June 4, 2002
    Assignees: Ambion, Inc., Cenetron Diagnostics, LLC
    Inventors: Brittan L. Pasloske, Dwight B. DuBois, David M. Brown, Matthew M. Winkler
  • Patent number: 6395470
    Abstract: The present invention relates to methods and compositions that provide a positive control to identify inhibition during a signal amplification reaction. The methods and compositions of the present invention are designed to run in the same tube or assay environment as the experimental or target sample and contain a copy of the target sequence in an inverted form.
    Type: Grant
    Filed: October 30, 1998
    Date of Patent: May 28, 2002
    Assignee: Cenetron Diagnostics, LLC
    Inventors: Cindy R. WalkerPeach, Dwight B. Dubois
  • Publication number: 20010006800
    Abstract: The present invention relates to methods and compositions that provide a positive control to identify inhibition during a signal amplification reaction. The methods and compositions of the present invention are designed to run in the same tube or assay environment as the experimental or target sample and contain a copy of the target sequence in an inverted form.
    Type: Application
    Filed: October 30, 1998
    Publication date: July 5, 2001
    Inventors: CINDY R. WALKERPEACH, DWIGHT B. DUBOIS
  • Patent number: 5919625
    Abstract: The present invention is directed to the process of creating a recombinant nucleic acid standard which is resistant to ribonuclease digestion and is non-infectious. A single strand of recombinant nucleic acid is encapsidated by bacteriophage proteins. The recombinant nucleic acid is a hybrid sequence encoding bacteriophage proteins and a specific non-bacteriophage sequence. A non-bacteriophage RNA sequence can be used as an RNA standard to help quantify the number of RNA molecules in an unknown sample. The recombinant RNA in its packaged form is highly resistant to ribonucleases, insuring that the RNA standard is not compromised by inadvertent ribonuclease contamination. These ARMORED RNA.TM. standards are ideal as RNA standards for the quantification of RNA viruses such as HIV and HCV from human body fluids such as blood and cerebrospinal fluid.
    Type: Grant
    Filed: April 29, 1997
    Date of Patent: July 6, 1999
    Assignees: Ambion, Inc., Cenetron Diagnostics, LLC
    Inventors: Dwight B. DuBois, Matthew M. Winkler, Brittan L. Pasloske
  • Patent number: 5677124
    Abstract: The present invention is directed to the process of creating a recombinant nucleic acid standard which is resistant to ribonuclease digestion and is non-infectious. A single strand of recombinant nucleic acid is encapsidated by bacteriophage proteins. The recombinant nucleic acid is a hybrid sequence encoding bacteriophage proteins and a specific non-bacteriophage sequence. A non-bacteriophage RNA sequence can be used as an RNA standard to help quantify the number of RNA molecules in an unknown sample. The recombinant RNA in its packaged form is highly resistant to ribonucleases, insuring that the RNA standard is not compromised by inadvertent ribonuclease contamination. These "ARMORED RNA" standards are ideal as RNA standards for the quantification of RNA viruses such as HIV and HCV from human body fluids such as blood and cerebrospinal fluid.
    Type: Grant
    Filed: July 3, 1996
    Date of Patent: October 14, 1997
    Assignees: Ambion, Inc., Cenetron Diagnostics LLC
    Inventors: Dwight B. DuBois, Matthew M. Winkler, Brittan L. Pasloske
  • Patent number: D568733
    Type: Grant
    Filed: April 26, 2007
    Date of Patent: May 13, 2008
    Inventors: Dwight B. DuBois, Timothy W. Murray